| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911320 | Lung Cancer | 2012 | 6 Pages |
Abstract
Biweekly gemcitabine and low-dose carboplatin combination chemotherapy showed acceptable efficacy, toxicity, and tolerability in those aged â¥76 years with NSCLC. Further investigations with a large population are required to confirm our results.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Hideki Kusagaya, Naoki Inui, Masato Karayama, Yutaro Nakamura, Shigeki Kuroishi, Koshi Yokomura, Mikio Toyoshima, Toshihiro Shirai, Masafumi Masuda, Takashi Yamada, Kazumasa Yasuda, Takafumi Suda, Kingo Chida,